Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Mantel, Hendrik T J ^a   Westerkamp, Andrie C ^a   Adam, René ^b,i   Bennet, William F ^c,i   Seehofer, Daniel ^d   Settmacher, Utz ^e   Sánchez Bueno, Francisco ^f   Prous, Joan Fabregat ^g   Boleslawski, Emmanuel ^h   Friman, Styrbjörn ^c   Porte, Robert J ^a   Lehner, Frank ^j   Klempnauer, Jurgen ^j   Ericzon, Bo Göran ^k   Croner, Roland ^l   Pratschke, Johann ^m   Sucher, Robert ^m   Kaiser, Gernot ⁿ   Muscari, Fabrice ^o   Fourtanier, Gilles ^o   Mazzaferro, Vincenzo ^p   Citterio, Davide ^p   Salizzoni, Mauro ^q   Troisi, Roberto ^r   Haantjes, Ivo ^r   Gugenheim, Jean ^s   Laurent, Alexis ^t   Stippel, Dirk ^u   Krawczyk, Marek ^v   Isoniemi, Helena ^w   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HÔPITAL PAUL BROUSSE   (France)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^f HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h UNIV LILLE   (France)

ⁱ European Liver Transplant Registry (ELTR)   (France)

^j HANNOVER MEDICAL SCHOOL   (Germany)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^m INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

^o CHU RANGUEIL   (France)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q UNIVERSITY OF TURIN   (Italy)

^r GHENT UNIVERSITY HOSPITAL   (Belgium)

^s CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^t HENRI MONDOR HOSPITAL   (France)

^u UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^v MEDICAL UNIVERSITY OF WARSAW   (Poland)

^w HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GEMCITABINE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOMYCIN; OXALIPLATIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT SELECTION; REGISTER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; BILE DUCT NEOPLASMS; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; KLATSKIN TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; SURVIVAL RATE;

ADULT; BILE DUCT NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KLATSKIN TUMOR; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; REGISTRIES; SURVIVAL RATE;

EID: 84974814466     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156127     Document Type: Article

References (22)

1. Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, et al. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000; 7(2):155-162. PMID: 10982608
2. IJitsma AJ, Appeltans BM, de Jong KP, Porte RJ, Peeters PM, Slooff MJ. Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma: a report of 42 cases. J Gastrointest Surg 2004 Sep-Oct; 8(6):686-694. PMID: 15358329
3. Dinant S, Gerhards MF, Rauws EA, Busch OR, Gouma DJ, van Gulik TM. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor). Ann Surg Oncol 2006 Jun; 13(6):872-880. PMID: 16614876
4. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, et al. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011 Mar; 18(3):651-658. doi:10.1245/s10434-010-1325-4 PMID: 20945107
5. Matsuo K, Rocha FG, Ito K, D'Angelica MI, Allen PJ, Fong Y, et al. The Blumgart preoperative staging system for hilar cholangiocarcinoma: analysis of resectability and outcomes in 380 patients. J Am Coll Surg 2012 Sep; 215(3):343-355. doi:10.1016/j.jamcollsurg.2012.05.025 PMID: 22749003
6. Gomez D, Patel PB, Lacasia-Purroy C, Byrne C, Sturgess RP, Palmer D, et al. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma. Eur J Surg Oncol 2014 Jan; 40(1):77-84. doi:10.1016/j.ejso.2013.10.009 PMID: 24262111
7. Neuhaus P, Thelen A, Jonas S, Puhl G, Denecke T, Veltzke-Schlieker W, et al. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma. Ann Surg Oncol 2012 May; 19(5):1602-1608. doi:10.1245/s10434-011-2077-5 PMID: 21964888
8. Thelen A, Neuhaus P. Liver transplantation for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2007; 14(5):469-475. PMID: 17909715
9. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000 Apr 27; 69(8):1633-1637. PMID: 10836374
10. Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, et al. Transplantation for hilar cholangiocarcinoma. Liver Transpl 2004 Oct; 10(10 Suppl 2):S65-8. PMID: 15382214
11. Hassoun Z, Gores GJ, Rosen CB. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma. Surg Oncol Clin N Am 2002 Oct; 11(4):909-921. PMID: 12607579
12. Gores GJ, Darwish Murad S, Heimbach JK, Rosen CB. Liver transplantation for perihilar cholangiocarcinoma. Dig Dis 2013; 31(1):126-129. doi:10.1159/000347207 PMID: 23797134
13. Bismuth H. Revisiting liver transplantation for patients with hilar cholangiocarcinoma: the Mayo Clinic proposal. Liver Transpl 2000 May; 6(3):317-319. PMID: 10827232
14. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005Sep; 242(3):451-8; discussion 458-61. PMID: 16135931
15. Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ. Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg 2012 Jul; 215(1):31-8; discussion 38-40. doi:10.1016/j.jamcollsurg.2012.03.014 PMID: 22621893
16. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004 May; 24(2):201-207. PMID: 15192792
17. Gleeson FC, Rajan E, Levy MJ, Clain JE, Topazian MD, Harewood GC, et al. EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc 2008 Mar; 67(3):438-443. PMID: 18061597
18. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002 Sep; 2(8):774-779. PMID: 12243499
19. Salgia RJ, Singal AG, Fu S, Pelletier S, Marrero JA. Improved post-transplant survival in the United States for patients with cholangiocarcinoma after 2000. Dig Dis Sci 2014 May; 59(5):1048-1054. doi:10.1007/s10620-013-2626-9 PMID: 23504331
20. Mantel HT, Rosen CB, Heimbach JK, Nyberg SL, Ishitani MB, Andrews JC, et al. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma. Liver Transpl 2007 Oct; 13(10):1372-1381. PMID: 17427173
21. Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, et al. A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am J Gastroenterol 2004 Sep; 99(9):1675-1681. PMID: 15330900
22. Duignan S, Maguire D, Ravichand CS, Geoghegan J, Hoti E, Fennelly D, et al. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience. HPB (Oxford) 2014 Jan; 16(1):91-98.